Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT)
- PMID: 17490918
- DOI: 10.1016/j.cct.2007.03.004
Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT)
Abstract
Objective: To test the primary study hypothesis that a physician-delivered coronary heart disease risk evaluation and communication program can lower patients' predicted 10-year risk of myocardial infarction or death due to coronary heart disease by 10% within 6 months compared to usual care.
Design: Prospective, parallel group, open-label, controlled, cluster-randomized multinational trial; the study site is the unit of randomization.
Setting: Patients were recruited from 106 general practices located in nine European countries.
Patients: Men and women aged 45 to 64 (N=1500) with a documented history of hypertension (treated or untreated), systolic blood pressure > or =140 mmHg (or > or =130 mmHg in the presence of renal or kidney disease), no history of cardiovascular disease, and a predicted 10-year risk of myocardial infarction or death due to coronary heart disease > or =10%.
Intervention: Sites were randomized to deliver a physician-directed coronary heart disease risk communication and education program or usual care. The intervention program included informing patients of their 10-year risk of myocardial infarction or death due to coronary heart disease, educating patients about modifiable risk factors and their control, and three follow-up phone calls by a physician or study nurse.
Main outcome measure: Predicted 10-year risk of myocardial infarction or death due to coronary heart disease at 6 months.
Conclusions: REACH OUT will evaluate a novel, patient-focused, physician-implemented application of coronary heart disease risk equations. Results of the study will be of practical relevance to physicians, health care organizations, and those who issue clinical guidelines for the reduction of cardiovascular risk.
Similar articles
-
Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.Am J Kidney Dis. 2009 Aug;54(2):307-17. doi: 10.1053/j.ajkd.2009.03.025. Epub 2009 Jun 17. Am J Kidney Dis. 2009. PMID: 19535190 Clinical Trial.
-
Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design.Am Heart J. 2008 Apr;155(4):609-14. doi: 10.1016/j.ahj.2007.11.011. Epub 2008 Feb 21. Am Heart J. 2008. PMID: 18371466 Clinical Trial.
-
Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM).Arch Intern Med. 2011 Jan 24;171(2):134-40. doi: 10.1001/archinternmed.2010.510. Arch Intern Med. 2011. PMID: 21263103 Clinical Trial.
-
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.Circulation. 2007 May 15;115(19):2549-69. doi: 10.1161/CIRCULATIONAHA.107.182615. Circulation. 2007. PMID: 17502590 Review.
-
Coffee, caffeine, and coronary heart disease.Curr Opin Lipidol. 2007 Feb;18(1):13-9. doi: 10.1097/MOL.0b013e3280127b04. Curr Opin Lipidol. 2007. PMID: 17218826 Review.
Cited by
-
Risk assessment in the prevention of cardiovascular disease in low-resource settings.Indian Heart J. 2016 May-Jun;68(3):391-8. doi: 10.1016/j.ihj.2015.07.004. Epub 2015 Aug 29. Indian Heart J. 2016. PMID: 27316504 Free PMC article. Review.
-
A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile.Int J Clin Pract. 2008 Oct;62(10):1484-98. doi: 10.1111/j.1742-1241.2008.01872.x. Epub 2008 Aug 7. Int J Clin Pract. 2008. PMID: 18691228 Free PMC article. Clinical Trial.
-
Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature.BMC Health Serv Res. 2008 Mar 20;8:60. doi: 10.1186/1472-6963-8-60. BMC Health Serv Res. 2008. PMID: 18366711 Free PMC article.
-
Tailored interventions to address determinants of practice.Cochrane Database Syst Rev. 2015 Apr 29;2015(4):CD005470. doi: 10.1002/14651858.CD005470.pub3. Cochrane Database Syst Rev. 2015. PMID: 25923419 Free PMC article.
-
Risk scoring for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2017 Mar 14;3(3):CD006887. doi: 10.1002/14651858.CD006887.pub4. Cochrane Database Syst Rev. 2017. PMID: 28290160 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources